Application

18516360 · IMMUNOGENIC COMPOSITIONS TARGETING RECURRENT CANCER MUTATIONS AND METHODS OF USE THEREOF

Filed 2023-11-21 · Abandoned The official file ↗ · Art unit 1645 · Examiner Lakia J Jackson-Tongue Typical · CPC C07K 14/4748 · Advaxis, Inc. · Advaxis, Inc./Alston & Bird LLP

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

15.8 mo

to disposition 23.0 mo

Statutes raised

102 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.